The level of ferritin in diabetic and nondiabetic patients with acute myocardial infarction

Turkish Journal of Medical Sciences

Volumn 35, Issue 1, 2005, Pages 25-34

  Mert, Meral ^a,b   Korkmaz, Müge ^a   Temizel, Mustafa ^a   Acar, Metin ^a  

^a Okmeydani Teaching Hospital   (Turkey)

^b Toplu Konut 3 Etap ^*  (Turkey)

Author keywords

Diabetes Mellitus; Ferritin; Myocardial Infarction

Indexed keywords

ASSAYS; CARDIOLOGY; DATA REDUCTION; DISEASE CONTROL; ENZYMES; IRON; PATIENT TREATMENT; RISK ASSESSMENT;

DIABETES MELLITUS; FERRITIN; IMMUNORADIOMETRIC ASSAY (IRMA); TOTAL IRON BINDING CAPACITY (TIBC);

PROTEINS;

ANTICOAGULANT AGENT; EDETATE POTASSIUM; EDETIC ACID DERIVATIVE; FERRENE; FERRITIN; FERROZINE; HEART ENZYME; IRON; IRON DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ANALYSIS OF VARIANCE; ANALYZER; ANAMNESIS; ARTICLE; ASSAY; BLOOD SAMPLING; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; IRON BINDING CAPACITY; IRON BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RANK SUM TEST; RISK FACTOR;

EID: 14944382342     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lindahl B, Toss H, Siegbahn A et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Eng J Med 343: 1139-47, 2000.
2. Cottin Y, Doise JM, Maupoil V et al. Plasma iron status and lipid peroxidation following thrombolytic therapy for acute myocardial infarction. Fundam Clin Pharmacol 12: 236-41, 1998.
3. Kameneva MV, Watach MJ, Borovetz HS. Gender difference in rheologic properties of blood and risk of cardiovascular diseases. Clin Hemorheol Microcirc 21: 357-63, 1999.
4. Moroz C, Bessler H, Katz M et al. Elevated serum ferritin level in acute myocardial infarction. Biomed Pharmacother 51: 126-30, 1997.
5. Fernandez F, Lopez Bermejo A, Ricart W. Blood letting in high ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 25: 2249-55, 2002.
6. Juhan Vague I, Morange P, Renucci JF et al. Fibrinogen, obesity and insulin resistance. Blood Coagul Fibrin 10: 25-8, 1999.
7. Jiang R, Manson JE, Meigs JB et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 11; 291: 711-7, 2004.
8. Lao TT, Ho LF. Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus. Diabetes Care 27: 650-6, 2004.
9. Ross R. Atherosclerosis an inflammatory disease. N Eng J Med 340: 115-26, 1999.
10. Krobot K, Hense HW, Cremer P et al. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age and sex: results from the second MONICA Augsburg survey 1989-1990. Arteriscler Thromb 12: 780-8, 1992.
11. Mendhall MA, Patel P, Ballam L et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312: 1061-5, 1996.
12. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 26: 1, 2003
13. Bertrand ME, Simons ML, Fox KA et al. Management of acute coronary syndromes: Recommendations of the Task Force of the European Society of Cardiology. European Heart Journal 21, 1406-1432, 2000.
14. Hughes K, Choo M, Kuperan P et al. Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. Atherosclerosis 136: 25-31, 1998.
15. Oba K, Yamashita N, Okazaki K et al. High levels of serum ferritin in elderly patients with non-insulin dependent diabetes mellitus. Nippon Ronen Igakkai Zasshi 34: 305-11, 1997.
16. Canturk Z, Cetinarslan B, Tarkun I et al. Serum ferritin levels in poorly and well controlled diabetes mellitus. Endocr Res 29: 299-306, 2003.
17. Toumanien TP, Punnonen K, Nyssonen K et al. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 27: 446, 1999.
18. Halle M, Konig D, Berg A et al. Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis 10: 235-40, 1997.
19. Kraml P, Andel M, Malkova J et al. Serum ferritin levels in subjects at high risk of atherosclerosis. Centr Eur J Public Health Feb 8: 4-9, 2000.
20. Carenini A, Ronchi D, Garbetta F et al. Serum ferritin in type 1 diabetes. Clin Chim Acta 31: 165-70, 1985.
21. Sempos CT, Looker AC, Gillum RE et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 10: 441-8, 2000.
22. Ascherio A, Rimm EB, Giovannucci E et al. Blood donations and risk of coronary heart disease in men. Circulation 2: 52-7, 2001.
23. Klipstein-Grobusch K, Koster JF, Grobee DE et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 69: 1231-6, 1999.
24. Armaganijan D, Batlouni M. Serum ferritin levels and other indicators of organic iron as risk factors or markers in coronary artery disease. Rev Port Cardiol. 22: 185-95, 197-201, 2003.